Find News

Filter articles

Applied Filters

Showing 81 to 90 of 130 results

US top, India bottom in biopharma innovation report


The US has been ranked as the country that contributes most to global biopharmaceutical innovation through the use of its policies.

GSK to widen access to medicines in world’s poorest countries


Pharmaceutical company GSK has adopted a new approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.

Teva announces global re-brand


Pharmaceutical company Teva is set to re-brand itself as part of its plan to build “a new breed of healthcare company”.

New drugs from Gilead and Merck set for ‘blockbuster’ status, report shows


Drugs made by pharmaceutical companies including Abbvie, Gilead, and Merck are set to achieve “blockbuster” status by 2020, according to a report.

Generic companies ink hepatitis C deal with BMS

International, US26-01-2016

Pharmaceutical companies including Cipla and Natco Pharma have signed a sub-licensing deal enabling them to produce a generic version of Bristol Myers Squibb’s hepatitis C drug Daclatasvir.

Patent searching app for pharma industry launched

India, International18-01-2016

An individual working at India-based healthcare organisation Micro Labs has launched a mobile app which obtains relevant data on patents for pharmaceutical and biotechnology industry professionals.

Roche and Glenmark settle cancer drug patent row

Argentina, Australia, Belarus, Brazil, Brunei, Canada, Chile, China, EU, France, Germany, India, Ireland, Israel, Jordan, Kazakhstan, Malaysia, Mexico, Netherlands, New Zealand, Norway, Peru, Poland, Republic of Ireland, Russia, Singapore, South Africa, South Korea, Sweden, Switzerland, Taiwan, Thailand, Turkey, UK, US, Vietnam04-01-2016

Roche has settled its patent litigation dispute with India-based Glenmark Pharmaceuticals centring on cancer drug Tarceva.

Dr Reddy’s secures thrombosis drug rights in $17.5m deal


Indian pharmaceutical company Dr Reddy’s has agreed a deal to buy global intellectual property rights to a generic version of GSK’s deep vein thrombosis treatment Arixtra (fondaparinux sodium) as part of a $17.5 million deal with a partner company.

Piper Alderman adds special counsel in Australia


Australia-based law firm Piper Alderman has hired Julian Grover as a special counsel in the firm’s intellectual property practice.

NGOs urge Obama to change stance on LDCs patent waiver


US President Barack Obama has been urged by several non-government organisations to permanently exempt the world’s least developed countries from having to grant patents for pharmaceutical products.

Showing 81 to 90 of 130 results